Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by 
human Tau δK280

Dennissen, Frank Johannes A.; Anglada-Huguet, Marta; Sydow, Astrid; Mandelkow, Eckhard; Mandelkow, Eva-Maria

doi:10.1073/pnas.1603119113

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau δK280

MPS-Authors

/persons/resource/persons147310

Sydow, Astrid
Eckhard Mandelkow, Emeriti, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

/persons/resource/persons94203

Mandelkow, Eckhard
Eckhard Mandelkow, Emeriti, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

/persons/resource/persons128150

Mandelkow, Eva-Maria
Eckhard Mandelkow, Emeriti, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Dennissen, F. J. A., Anglada-Huguet, M., Sydow, A., Mandelkow, E., & Mandelkow, E.-M. (2016). Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau δK280. Proceedings of the National Academy of Sciences of the United States of America, 113(41), 11597-11602. doi:10.1073/pnas.1603119113.

引用: https://hdl.handle.net/11858/00-001M-0000-002B-A8F3-2

要旨

要旨はありません